FR2995211B1 - Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique - Google Patents

Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique

Info

Publication number
FR2995211B1
FR2995211B1 FR1359833A FR1359833A FR2995211B1 FR 2995211 B1 FR2995211 B1 FR 2995211B1 FR 1359833 A FR1359833 A FR 1359833A FR 1359833 A FR1359833 A FR 1359833A FR 2995211 B1 FR2995211 B1 FR 2995211B1
Authority
FR
France
Prior art keywords
dermocosmal
cosmetics
field
receptor agonists
opioid receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1359833A
Other languages
English (en)
Other versions
FR2995211A1 (fr
Inventor
Daniel Auriol
Fabrice Lefevre
Kuno Schweikert
Gerard Redziniak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Induchem Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Induchem Holding AG filed Critical Induchem Holding AG
Priority to FR1359833A priority Critical patent/FR2995211B1/fr
Publication of FR2995211A1 publication Critical patent/FR2995211A1/fr
Application granted granted Critical
Publication of FR2995211B1 publication Critical patent/FR2995211B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR1359833A 2012-03-23 2013-10-10 Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique Expired - Fee Related FR2995211B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1359833A FR2995211B1 (fr) 2012-03-23 2013-10-10 Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305335.7A EP2641588B1 (fr) 2012-03-23 2012-03-23 Utilisation d'agonistes du récepteur opioïde delta dans le domaine cosmétique et dermocosmétique
FR1352550A FR2988294B1 (fr) 2012-03-23 2013-03-21 Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique
FR1359833A FR2995211B1 (fr) 2012-03-23 2013-10-10 Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique

Publications (2)

Publication Number Publication Date
FR2995211A1 FR2995211A1 (fr) 2014-03-14
FR2995211B1 true FR2995211B1 (fr) 2017-11-10

Family

ID=45929468

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1352550A Expired - Fee Related FR2988294B1 (fr) 2012-03-23 2013-03-21 Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique
FR1359833A Expired - Fee Related FR2995211B1 (fr) 2012-03-23 2013-10-10 Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1352550A Expired - Fee Related FR2988294B1 (fr) 2012-03-23 2013-03-21 Utilisation d'agonistes des recepteurs opioides delta dans le domaine de la cosmetique et de la dermocosmetique

Country Status (4)

Country Link
US (1) US9107852B2 (fr)
EP (1) EP2641588B1 (fr)
CH (1) CH706322B1 (fr)
FR (2) FR2988294B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114373519A (zh) * 2021-12-31 2022-04-19 苏州佩德生物医药有限公司 一种trpv3抑制剂的虚拟筛选方法、药物先导化合物及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750325B1 (fr) 1996-06-28 1998-07-31 Oreal Utilisation en cosmetique d'un poly(acide 2-acrylamido 2- methylpropane sulfonique) reticule et neutralise a au moins 90 % et compositions topiques les contenant
FR2757767B1 (fr) 1996-12-27 1999-02-05 Oreal Composition topique contenant au moins une proteine d'origine vegetale et/ou une proteine d'origine animale et une poly(acide 2-acrylamido 2-methylpropane sulfonique) reticule
EP1595541A1 (fr) * 2004-05-12 2005-11-16 Alcasynn Pharmaceuticals Gmbh Utilisation d'antagonistes aux récepteurs opioides pour prévenir et/ou traiter les maladies associées à la cible calcineurine
WO2009012376A1 (fr) 2007-07-17 2009-01-22 The Ohio State University Research Foundation Compositions et méthodes se rapportant aux soins de la peau

Also Published As

Publication number Publication date
US20130251657A1 (en) 2013-09-26
CH706322A2 (fr) 2013-09-30
EP2641588A1 (fr) 2013-09-25
FR2988294A1 (fr) 2013-09-27
FR2995211A1 (fr) 2014-03-14
FR2988294B1 (fr) 2017-09-15
EP2641588B1 (fr) 2017-11-22
US9107852B2 (en) 2015-08-18
CH706322B1 (fr) 2017-08-31

Similar Documents

Publication Publication Date Title
FR21C1021I2 (fr) Compositions d'arni de pcsk9 et methodes d'utilisation associees
EP2844292A4 (fr) Antagonistes de st2l et procédés d'utilisation
EP2912178A4 (fr) Super-activateurs et procédés d'utilisation de ceux-ci
EP2852404A4 (fr) ANTICORPS ET IMMUNOCONJUGUÉS ANTI-Ly6E ET PROCÉDÉS D'UTILISATION
EP2895217A4 (fr) Dispositifs d'administration et procédés d'augmentation de la peau
SI3067358T1 (sl) Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba
EP2833879A4 (fr) Inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques, et procédés d'utilisation de ceux-ci
EP2897661A4 (fr) Revêtements par centrifugation par élution médicamenteuse et procédés d'utilisation
EP2920702A4 (fr) Fourniture de support d'orientation dans des réceptacles
EP2870138A4 (fr) Benzamides n-substitués et leurs procédés d'utilisation
EP2920319A4 (fr) Enzymes spécifiques de site et procédés d'utilisation associés
EP2812032A4 (fr) Applicateurs d'antiseptique et techniques de conditionnement
EP2709991A4 (fr) Utilisation d'antagonistes de cxcr4
HRP20181364T1 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
EP2834421A4 (fr) Agents stabilisateurs et leurs procédés d'utilisation
EP2859179A4 (fr) Crépines de forage et procédés d'utilisation associés
IT1398930B1 (it) Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi.
ZA201403200B (en) N-(pyruid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use
EP2673381A4 (fr) Biosondes et procédés d'utilisation de celles-ci
EP2863858A4 (fr) Systèmes de soutien pour patient et leurs procédés d'utilisation
EP2895181A4 (fr) Compositions topiques et procédés d'utilisation
EP2579870A4 (fr) Agonistes trkb et leurs procédés d'utilisation
EP2852397A4 (fr) Variants d'huwentoxine iv et procédés d'utilisation
EP2931313A4 (fr) Formulations en solution d'anticorps anti-il-23p19 modifiés
PL2922576T3 (pl) Sposoby podawania i oceny leków wychwytujących azot do leczenia encefalopati wątrobowej

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLSC Publication of the preliminary search report

Effective date: 20170331

PLFP Fee payment

Year of fee payment: 6

TP Transmission of property

Owner name: GIVAUDAN FINANCE SA, CH

Effective date: 20180828

TP Transmission of property

Owner name: GIVAUDAN SA, CH

Effective date: 20181031

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20251105